Strategic vision, paired with execution discipline.
Michael H. Loechel is a Strategy, Innovation & Transformation Leader who helps global biopharmaceutical organizations define where to compete, how to win, and how to make large-scale change stick.
With over 25 years of experience, Michael brings a rare combination of strategic vision and execution discipline — from shaping enterprise innovation agendas to leading complex, multi-workstream transformations end-to-end. Direct commercial experience, built earlier in his career, grounds his strategic advice.
Education & Recognition
- Professional Experience
-
- President & Co-Founder, Axioma Group, Inc. (2016–Present)
- Strategy and Operations Consultant, Deloitte Consulting LLP
- Director, Strategic Accounts, PDR Network
- Associate Director, Boehringer Ingelheim Pharmaceuticals
- Director, Technology Strategy, Pfizer Inc.
- Distinctions
-
- U.S. Army National Guard Veteran
- Bilingual, English and Spanish
- Certified Strategy Professional, George Washington University
- 11-year tenure at Pfizer, recognized with 35+ internal "STARS" Awards
- Education
-
- M.S., Management — North Carolina State University, Poole College of Management
- B.A., International Studies — The Ohio State University, full scholarship
- Executive education at Harvard Law School, Harvard T.H. Chan School of Public Health, and NYU Stern
- Faculty & Thought Leadership
-
- AMA Faculty Member — Fundamentals of Strategic Planning, and Managing Chaos
- Certified Applied Creativity Facilitator, Basadur Levels I & II
Systems thinking, not just slide decks.
Strategy fails most often at the seams — between the choice of where to compete and the operating reality of how a large organization actually moves. Michael's approach treats those as one problem, not two separate engagements, drawing on a background that spans enterprise strategy, innovation program design, and hands-on transformation execution across some of the industry's largest organizations.